This article is more than 5 years old. Information may no longer be current.

Johnson & Johnson voluntarily recalls 13 affected lots of 1-Day Acuvue TruEye brand contact lenses

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Johnson & Johnson Vision Care has instituted a voluntary recall of 13 affected lots of its 1-Day Acuvue TruEye brand contact lenses, according to a press release from the Health Sciences Authority in Singapore, which is overseeing the recall.

The recall, which follows reports filed in Japan of contact lens-related eye irritation and discomfort when inserting affected lenses, led Johnson & Johnson to conduct an investigation that uncovered a time-specific problem linked to a rinsing mechanism on a manufacturing line, the release said.

The affected lot numbers — all manufactured in Ireland and distributed in Singapore — are: 4922380103; 4922510105; 4922860803; 4922861008; 4922861107; 4922870109; 4922880504; 4922881006; 4922821200; 4922801103; 4922520201; 4922540105; and 4922540103. The HSA has advised the company to halt distribution of all affected lots and to inform all retailers to discontinue sales of these lenses. While the HSA says that additional lots were affected, those lots were not distributed in Singapore by Johnson & Johnson Vision Care, according to the release.

So far this year, Johnson & Johnson Vision Care has supplied 914 boxes of the affected lots to optical outlets in Singapore. However, since the recall began on Aug. 19, Johnson & Johnson has received no reports of adverse events linked to use of these contact lenses in Singapore or in other markets, including the United States.

"Johnson & Johnson Vision Care affiliates in Japan, Asia and Europe are working in cooperation with regulatory authorities, eye care professionals and others who distribute our products to retrieve, destroy and replace all 1-Day Acuvue TruEye (narafilcon A) product that may be affected by this voluntary recall," Gary Esterow, senior director of public relations for Johnson & Johnson's Vistakon division, told Ocular Surgery News in a prepared statement. "The company is also providing replacement contact lenses to customers who have any of the products with the affected lot numbers."

The recall is expected to conclude by next week.